DUSP29
Dual specificity phosphatase 29
Also known as: DUPD1, DUS29_HUMAN, DUSP27
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68J44
- Gene
- DUSP29
- Ensembl
- ENSG00000188716
- Chromosome
- 10
- Canonical length
- 220 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein homodimerization activity and protein tyrosine/serine/threonine phosphatase activity. Involved in protein dephosphorylation. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
220 residues, UniProt reviewed canonical sequence.
>Q68J44|DUSP29
1 MTSGEVKTSL KNAYSSAKRL SPKMEEEGEE EDYCTPGAFE LERLFWKGSP QYTHVNEVWP
61 KLYIGDEATA LDRYRLQKAG FTHVLNAAHG RWNVDTGPDY YRDMDIQYHG VEADDLPTFD
121 LSVFFYPAAA FIDRALSDDH SKILVHCVMG RSRSATLVLA YLMIHKDMTL VDAIQQVAKN
181 RCVLPNRGFL KQLRELDKQL VQQRRRSQRQ DGEEEDGRELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DUSP29 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 97 nTPM
- tongue: 13 nTPM
- salivary gland: 0.9 nTPM
- esophagus: 0.6 nTPM
- heart muscle: 0.6 nTPM
- prostate: 0.6 nTPM
Single-cell type
- myonuclei: 1.1 nCPM
- brain excitatory neurons: 0.1 nCPM
- brain inhibitory neurons: 0.1 nCPM
- distal convoluted tubule cells: 0.1 nCPM
- hofbauer cells: 0.1 nCPM
- other brain neurons: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- amygdala: 0.1 nTPM
- cerebellum: 0.1 nTPM
- hypothalamus: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glucose homeostasis
- muscle cell differentiation
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of MAPK cascade
- protein dephosphorylation
Molecular functions
- MAP kinase phosphatase activity
- protein homodimerization activity
- protein serine/threonine phosphatase activity
- protein tyrosine phosphatase activity
- protein tyrosine/serine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dual specificity phosphatase, catalytic domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, active site
- Atypical dual specificity phosphatase, subfamily A
- Dual specificity protein phosphatase domain
- Protein-tyrosine phosphatase-like
- Dual specificity phosphatase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DUSP29 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DUSP29 as an antibody target. Whether an autoantibody or antibody against DUSP29 could matter depends on whether native DUSP29 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DUSP29 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DUSP29 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...